Glimisave MV 3.3 Tablet SR

Glimisave MV 3.3 Tablet SR is a prescription medicine designed to manage type 2 diabetes mellitus. It works through a triple combination of medicines that lower blood sugar by boosting insulin release, improving the body’s response to insulin, reducing glucose production in the liver, and slowing carbohydrate absorption in the intestine. This helps achieve stable and long-lasting glucose control.

The sustained-release formulation ensures a gradual effect throughout the day, supporting better sugar regulation when paired with healthy diet and physical activity.

Key Benefits

• Provides comprehensive control of blood sugar levels

• Long-acting formulation for steady effect

• Reduces the risk of diabetes-related health issues

• Supports improved daily glucose balance

Common Side Effects
Some individuals may experience mild digestive upset, diarrhea, stomach discomfort, dizziness, or weakness. These are often temporary but should be reported if persistent.

Mode of Action
This tablet contains Glimepiride, Metformin, and Voglibose. Glimepiride stimulates insulin release, Metformin decreases glucose output from the liver and increases insulin sensitivity, while Voglibose slows down carbohydrate digestion to prevent post-meal sugar spikes.